Austen Schalow
Austen Schalow, 27, appeared in La Crosse County Circuit court Tuesday on seven charges, including possession with intent to deliver cocaine, possession with intent to deliver narcotics, manufacture/deliver THC, possession with intent to deliver THC, possession with intent to deliver schedule IV drugs, maintaining a drug trafficking place, and possession of drug paraphernalia.
Last summer, a confidential informant told officers Schalow had showed them a photo of around 200 marijuana plants in his basement and stated Schalow said he paid a woman with cash or marijuana to come to his home for âsexual favors.â Officers in July 2020 began looking into Schalow, who is under supervision from the Wisconsin Department of Corrections Probation Office for domestic abuse related convictions, and have been monitoring his social media since.
Amazon Says Marijuana-Positive Drug Tests OK When Hiring For Some Jobs By Dawn Geske
on June 03 2021 1:26 AM Amazon has acquired the Australian-based e-commerce startup Selz which allows businesses to create their own online stores. like the Canadian-based firrm Shopify AFP / DENIS CHARLET
Amazon (AMZN) is adjusting its hiring policies in what may be considered a controversial move by changing its drug screening process.
As states across the U.S. make marijuana use legal, Amazon is updating its drug testing requirements for some job positions, where it previously disqualified people from employment if they tested positive for cannabis use.
But now, the e-commerce giant will allow marijuana-positive drug testing for jobs that are not regulated by the Department of Transportation, treating it the same as alcohol-positive tests. But Amazon said it will continue to drug and alcohol test after an incident on the job.
NOIDA, India, June 2, 2021 /PRNewswire/ A comprehensive overview of the Connected Drug Delivery Devices market is recently added by UnivDatos Market Insights to its humongous database. The
Tetra Bio-Pharma: Health Canada Accepts New Drug Submission for REDUVO as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
The Company approaches a significant milestone advancing from a pre-revenue biotech to in revenue
OTTAWA, ON / ACCESSWIRE / June 2, 2021 /
Tetra Bio-Pharma
Inc. ( Tetra or the Company ) (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announced today that Health Canada has accepted its New Drug Submission (NDS) for REDUVO and has formally entered the final review phase in the drug review process. If successful, REDUVO will be issued a Notice of Compliance (NOC) as well as a Drug Identification Number (DIN) which permits Tetra to market the drug in Canada and indicates the drug s official approval in Canada.
A Glouster woman who allegedly co-leads an area drug ring pleaded guilty to the charge of engaging in a pattern of corrupt activity, a second-degree felony, last Wednesday.